Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2024-08-14 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2024-08-14 English
Resignation of Statutory Auditor
Regulatory Filings
2024-08-13 English
Updates
Audit Report / Information Classification · 95% confidence The document is a detailed announcement regarding the resignation of the statutory auditors of a material subsidiary and the appointment of new statutory auditors. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes detailed disclosures as required by SEBI circulars. The content focuses on auditor changes, reasons for resignation, appointment details, and regulatory compliance disclosures. It does not contain financial statements or audit reports themselves but is an official disclosure about changes in auditors. This fits the category of Audit Report / Information (AR), which includes standalone audit-related announcements and auditor changes, excluding full annual reports. The document length and detail confirm it is not a brief announcement or a simple notification but a substantive audit-related disclosure.
2024-08-13 English
Updates
Major Shareholding Notification Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges regarding a request for re-classification of certain individuals from the 'Promoter and Promoters Group' category to the 'Public' category. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 31A. The content is about shareholding category changes and upcoming board meeting consideration. There are no financial statements, earnings data, or detailed reports. The document is a regulatory announcement about shareholding classification changes, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2024-08-07 English
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings Classification · 95% confidence The document is a formal report addressed to stock exchanges (NSE and BSE) regarding violations of the company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015. It details specific insider trading violations by immediate relatives of a designated person, actions taken by the company including penalties, and compliance measures. The content is regulatory in nature, reporting compliance and enforcement actions related to insider trading rules. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an announcement of a report publication but a regulatory compliance filing. Therefore, the document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-07 English
Updates
Regulatory Filings Classification · 95% confidence The document is a communication addressed to stock exchanges and depositories regarding the details of shares dematerialized during July 2024. It references Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and includes a certificate from the Registrar and Transfer Agent (RTA) confirming the dematerialized shares as of July 31, 2024. The content is an official notification about share dematerialization status, not a financial report, earnings release, or management discussion. It is a regulatory compliance filing informing the exchanges and depositories about share dematerialization details. The document length is short (3169 characters) and it serves as an announcement or notification rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.